Kingston Pharma LLC
Form 483 issued July 25, 2024 · Massena, New York
- Observations
- 1
- Pages
- 2
- FEI number
- 3012275336
In short: On July 25, 2024, FDA issued a Form 483 with 1 observation to Kingston Pharma LLC in Massena, New York (FEI 3012275336). Most observations concern dietary supplement CGMP; the most-cited regulation is 21 CFR 111.15 (what sanitation requirements apply to your physical plant and grounds?).
At a glance
1 of 1 observations on this 483 concern dietary supplement cgmp.
Most cited: 21 CFR 111.15(f)(5) (1×)
What FDA observed
Preview: the opening words of each observation- 01
The plumbing in your physical plant allows cross connection between piping systems that discharge waste water…
This inspection in context
Questions about this 483
What did FDA find at Kingston Pharma LLC?
FDA listed 1 observation on this Form 483, mostly about dietary supplement CGMP. The most-cited regulation is 21 CFR 111.15 (what sanitation requirements apply to your physical plant and grounds?). The opening words of each observation are shown on this page.
When was Kingston Pharma LLC inspected by FDA?
This Form 483 is dated July 25, 2024.
How do I get the full Form 483 for Kingston Pharma LLC?
Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.